Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure Academic Article uri icon

Overview

MeSH Major

  • Adrenergic beta-Antagonists
  • Carbazoles
  • Heart Failure
  • Propanolamines
  • Vasodilator Agents

abstract

  • Carvedilol produces clinical and hemodynamic improvement in patients who have severe heart failure despite treatment with angiotensin-converting enzyme inhibitors.

publication date

  • September 19, 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7664433

Additional Document Info

start page

  • 1499

end page

  • 506

volume

  • 92

number

  • 6